Inhibiting menin, a protein that supports leukemia growth and is already targeted to treat some forms of leukemia, also holds ...

AUSTIN, Texas & MONTREAL--(BUSINESS WIRE)--Forbius, a clinical-stage company that develops biologics for the treatment of cancer and fibrosis, announced today a collaboration agreement with the Icahn ...

Please provide your email address to receive an email when new articles are posted on . “If this is true, this could really change the field,” Parsegov, physician assistant in the division of ...

A decision to rename myeloproliferative neoplasms led to a plethora of developments in a space where there was once little interest. Name recognition. The term is often associated with Fortune 500 ...

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

Myeloid malignancies, and particularly myeloproliferative neoplasms (MPN), represent a dynamic spectrum of clonal disorders shaped by genetic, epigenetic and microenvironmental forces. This collection ...